PL360582A1 - Rybozydy puryny jako leki znoszące arytmię serca - Google Patents

Rybozydy puryny jako leki znoszące arytmię serca

Info

Publication number
PL360582A1
PL360582A1 PL01360582A PL36058201A PL360582A1 PL 360582 A1 PL360582 A1 PL 360582A1 PL 01360582 A PL01360582 A PL 01360582A PL 36058201 A PL36058201 A PL 36058201A PL 360582 A1 PL360582 A1 PL 360582A1
Authority
PL
Poland
Prior art keywords
antiarrhythmics
purine ribosides
ribosides
purine
mammals
Prior art date
Application number
PL01360582A
Other languages
English (en)
Other versions
PL205874B1 (pl
Inventor
Andrew A. Wolf
Original Assignee
Cv Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cv Therapeutics, Inc. filed Critical Cv Therapeutics, Inc.
Publication of PL360582A1 publication Critical patent/PL360582A1/pl
Publication of PL205874B1 publication Critical patent/PL205874B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
PL360582A 2000-09-08 2001-09-07 Zastosowanie agonisty receptora adenozyny A₁ do wytwarzania leku do leczenia arytmii serca PL205874B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23101100P 2000-09-08 2000-09-08
US30532801P 2001-07-13 2001-07-13

Publications (2)

Publication Number Publication Date
PL360582A1 true PL360582A1 (pl) 2004-09-06
PL205874B1 PL205874B1 (pl) 2010-06-30

Family

ID=26924751

Family Applications (1)

Application Number Title Priority Date Filing Date
PL360582A PL205874B1 (pl) 2000-09-08 2001-09-07 Zastosowanie agonisty receptora adenozyny A₁ do wytwarzania leku do leczenia arytmii serca

Country Status (17)

Country Link
US (1) US6537974B2 (pl)
EP (1) EP1315508B1 (pl)
JP (2) JP2004508336A (pl)
KR (1) KR20030040443A (pl)
CN (1) CN1482913A (pl)
AT (1) ATE262339T1 (pl)
AU (2) AU9259101A (pl)
CA (1) CA2421738C (pl)
DE (1) DE60102481T2 (pl)
ES (1) ES2215146T3 (pl)
HU (1) HUP0302685A3 (pl)
IL (2) IL154652A0 (pl)
MX (1) MXPA03001741A (pl)
NO (1) NO20030852D0 (pl)
NZ (1) NZ524390A (pl)
PL (1) PL205874B1 (pl)
WO (1) WO2002020024A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04010285A (es) * 2002-04-18 2005-02-03 Cv Therapeutics Inc Metodo para tratar arritmias que comprende la administracion de un agonista de adenosina a1 con un bloqueador beta, bloqueador del canal de calcio o un glucosido cardiaco.
US7902088B2 (en) 2004-03-15 2011-03-08 Sharp Laboratories Of America, Inc. High quantum efficiency silicon nanoparticle embedded SiOXNY luminescence device
US7781402B2 (en) * 2004-10-12 2010-08-24 Closed Loop Therapies Ltd. Methods and implantable devices for treating supraventricular arrhythmias

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364922A (en) * 1980-10-14 1982-12-21 University Of Virginia Alumni Patents Foundation Adenosine antagonists in the treatment and diagnosis of A-V node conduction disturbances
JPS57171998A (en) * 1981-04-15 1982-10-22 Fujisawa Pharmaceut Co Ltd Adenosine derivative and its salt, preparation thereof and medicinal composition containing the same
DE3138397A1 (de) * 1981-09-26 1983-04-07 Hoechst Ag, 6230 Frankfurt "arzneimittel, darin enthaltene vicinale dihydroxyalkylxanthine und herstellungsverfahren fuer diese xanthinverbindungen"
US4954504A (en) * 1986-11-14 1990-09-04 Ciba-Geigy Corporation N9 -cyclopentyl-substituted adenine derivatives having adenosine-2 receptor stimulating activity
US4980379A (en) * 1988-06-30 1990-12-25 The University Of Virginia Use of adenosine antagonists in the treatment of bradyarrhythmias and hemodynamic depression associated with cardiopulmonary resucitation and/or cardiovascular collapse
US5736528A (en) * 1993-10-28 1998-04-07 University Of Florida Research Foundation, Inc. N6 -(epoxynorborn-2-yl) adenosines as A1 adenosine receptor agonists
US5446046A (en) 1993-10-28 1995-08-29 University Of Florida Research Foundation A1 adenosine receptor agonists and antagonists as diuretics
DE69422417T2 (de) * 1993-10-29 2000-07-13 Daikin Industries, Ltd. Thermoplastische harzzusammensetzung und daraus hergestelltes laminat
WO1998006855A1 (en) * 1996-08-16 1998-02-19 The Texas A & M University System Compositions and methods for delivery of nucleic acids to hepatocytes
US5789416B1 (en) 1996-08-27 1999-10-05 Cv Therapeutics Inc N6 mono heterocyclic substituted adenosine derivatives

Also Published As

Publication number Publication date
CA2421738C (en) 2009-03-24
IL154652A0 (en) 2003-09-17
NZ524390A (en) 2005-02-25
KR20030040443A (ko) 2003-05-22
ES2215146T3 (es) 2004-10-01
PL205874B1 (pl) 2010-06-30
CA2421738A1 (en) 2002-03-14
DE60102481D1 (en) 2004-04-29
CN1482913A (zh) 2004-03-17
NO20030852L (no) 2003-02-24
JP2008255118A (ja) 2008-10-23
US6537974B2 (en) 2003-03-25
US20020055485A1 (en) 2002-05-09
MXPA03001741A (es) 2004-09-10
EP1315508A1 (en) 2003-06-04
AU2001292591B2 (en) 2004-06-03
HUP0302685A3 (en) 2005-02-28
JP2004508336A (ja) 2004-03-18
DE60102481T2 (de) 2005-02-24
HUP0302685A2 (hu) 2003-12-29
WO2002020024A1 (en) 2002-03-14
EP1315508B1 (en) 2004-03-24
IL154652A (en) 2008-11-26
ATE262339T1 (de) 2004-04-15
NO20030852D0 (no) 2003-02-24
AU9259101A (en) 2002-03-22

Similar Documents

Publication Publication Date Title
AP2002002598A0 (en) Purine derivatives.
AU5557800A (en) Thieno- and furopyrimidine derivatives as a2a-receptor antagonists
AP1442A (en) Purine derivatives
AP2001002287A0 (en) Purine derivatives.
AP2002002480A0 (en) Purine derivatives.
AP2001002361A0 (en) Purine derivatives.
IL164652A0 (en) Method of treating arrhythmias comprising administration of an A1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside
BR9815761A (pt) Processo a vácuo para a fabricação de copolìmeros de siloxano-oxialquileno
BR0011856A (pt) Agonistas de receptor a2a de n-pirazol
BR0014695A (pt) 5-(2-substituìdo-5-heterociclilsulfonilpirid-3-il)-dihi dropirazolo[4,3-d]pirimidin-7-onas como inibidoras de fosfodiesterase
MY141196A (en) Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
SI1297013T1 (sl) Uporaba TACI kot protitumorskega sredstva
MY126527A (en) Novel dihydropyrimidines
BG107171A (en) Purine derivatives
MXPA02006826A (es) Un inhibidor de division celular y un metodo de produccion del mismo.
WO2000072799A3 (en) Method and compositions for treating the inflammatory response
BR0011850A (pt) Agonistas de receptor a2a de propargil fenil éter
MY129445A (en) Compositions for treating inflammatory response
MY121046A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
IL135825A0 (en) Use of mirtazapine for treating sleep apneas
WO2004008286A3 (en) Arrangements and methods for treating a subject
AU9259101A (en) Purine ribosides as antiarrhythmics
YU47802A (sh) Postupci i kompozicije za levovirin
NZ516336A (en) Thiophene A2A receptor agonists
PL359409A1 (pl) Związki przydatne do wytwarzania leków o działaniu inhibitującym fosfodiesterazę IV

Legal Events

Date Code Title Description
RECP Rectifications of patent specification
RECP Rectifications of patent specification
LAPS Decisions on the lapse of the protection rights

Effective date: 20120907